Research
My research interests are primarily in health economics and industrial organization.
Recent working papers
A method for calculating the probability of collusion based on observed price patterns, with N Rudholm. Also available at SSRN 4605725.
Articles in international scientific journals
The Importance of the First Generic Substitution: Evidence from Sweden, with A Janssen. Journal of Economic Behavior and Organization 213, 1–25. https://doi.org/10.1016/j.jebo.2023.07.017 WP-version available at SSRN 4072191
A new approach to estimating state dependence in consumers' brand choices applied to 762 pharmaceutical markets, Journal of Industrial Economics 69(2), 443–483, 2021. WP-version
Price competition in pharmaceuticals – evidence from 1303 Swedish markets, with M A Bergman, Journal of Health Economics 61, 1-12, 2018. Results from three extensions Post-refereeing-version
Physicians prescribing originals causes welfare losses, with D Sundström, Economics Letters 170, 143-146, 2018. Post-refereeing-version
Federal Subsidization of State Expenditure to Reduce Political Budget Cycles, with T Aronsson, International Tax and Public Finance 24(3), 536-545, 2017.
Free view-only version
Post-refereeing-version
Reforming the Swedish pharmaceuticals market: Consequences for costs per defined daily dose, with M Bergman and N Rudholm. International Journal of Health Economics and Management, 16(3), 201-214, 2016.
Free view-only version
Post-refereeing-version
Parallel Imports and Mandatory Substitution Reform – A Kick or A Muff for Price Competition? The European Journal of Health Economics, 16(9), 969-983, 2015 (with M Koksal-Ayhan)
Free view-only version
Post-refereeing-version
Introducing waiting times for health care in a labor supply model for sickness absence, with D Andrén, Nordic Journal of Health Economics 3, 34-46, 2014 (Open Access)
WP-version
Present-Biased Preferences and Publicly Provided Private Goods. FinanzArchiv/Public Finance Analysis 70(2), 169-199, 2014. (with T Aronsson)
Post-refereeing-version
WP-version
The prescribing physician's influence on consumer choice between medically equivalent pharmaceuticals. Review of Industrial Organization 41, 207-222, 2012. (with N Rudholm)
Free view-only version
Post-refereeing-version
Electoral accountability in a country with two-tiered government, Public Choice 148, 531-546, 2011.
Free view-only version
Post-refereeing-version
Public goods and optimal paternalism under present-biased preferences, Economics Letters 113, 54-57, 2011 (with T Aronsson).
Post-refereeing-version
Price and welfare effects of a pharmaceutical substitution reform, Journal of Health Economics 29, 856-865, 2010.
Post-refereeing-version
Consumer information and pharmaceutical prices: Theory and Evidence, Oxford bulletin of Economics and Statistics 73(2), 230-254, 2011. (with N Rudholm)
Free view-only version
WP-version
Additional results
The effect of health care expenditure on sickness absence, The European Journal of Health Economics 11, 555-568, 2010.
Free view-only version
Post-refereeing-version
Inequality in mortality in Vietnam during a period of rapid transition, Social Science & Medicine 70, 232-239, 2010. (with N T Chuc, H D Phuc and L Lindholm)
Post-refereeing-version
Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Social Science & Medicine 69, 1643-1650, 2009.
Post-refereeing-version
Additional results
Sickness absence and health care in an economic federation, International Tax and Public Finance 14, 503-524, 2007.
Free view-only version
Post-refereeing-version
Fixed budgets as a cost containment measure for pharmaceuticals, The European Journal of Health Economics 7, 37-45, 2006 (with N Rudholm and M Wikström)
Free view-only version
WP-version
Thesis:
Economic policy in health care – sickness absence and pharmaceutical costs
Current research project as PI:
How is collusion initiated and implemented?—Evidence from hundreds of markets [Hur initieras och implementeras prissamordningar? Resultat från hundratals marknader] Project leader: David Granlund. Co-applicants, Samielle Drake, Umeå University, and Nicolas De Roos, University of Liverpool. Financed by the Swedish Research Council (Vetenskapsrådet) (amont: SEK 4,070,000). 2025–2027.
Efficiency and the public sector. Project leader: David Granlund. Co-applicants, Thomas Aronsson and Sofia Lundberg, both at Umeå University. Financed by the Jan Wallander and Tom Hedelius Foundation and the Tore Browaldhs Foundation. July 2025–June 2028. (amount: SEK 2,790,000, financing three PhD students during two years.)
Formations and break downs of collusions [Prissamordningars bildande och sammanbrott] Project leader: David Granlund. Financed by the Swedish Competition Authority [Konkurrensverket]. 2024–2026.